Luminal B with oestrogen receptor (ER) positive group; (3) HER2 amplified group; (4) triple-negative breast cancers (TNBCs, also called basal-like, lacking expression of ER, progesterone receptor (PR) and HER2). Here, PGR is linked to triple-negative breast carcinoma.